PBAC
‘Significant distress to patients’
Recent supply shortages for first-line migraine meds hit patients hard and increased workloads, according to a PBAC stakeholder meeting Calcitonin gene-related peptide (CRGP) therapies are recommended as first-line medications for …
May PBAC meeting scheduled
High volume of submissions prompts government to add extra Pharmaceutical Benefits Advisory Committee meeting in 2025 The Pharmaceutical Benefits Advisory Committee (PBAC) will hold an additional full meeting in May …
Women’s health PBAC boost
Endometriosis, OCP drug listings recommended to increase access and multiple treatment options for women The PBAC has recommended unrestricted benefit listings of drospirenone with ethinylestradiol (Yaz and Yasmin) oral contraceptive …
Government’s hands tied on medicinal cannabis PBS listing
Chronic pain patients who are struggling to cover the costs of medicinal cannabis treatments are being urged to talk to their pharmacists Legislation requiring medications to be approved by the …
‘A very welcome addition.’
PBAC recommends PBS listing of drug to treat endometriosis pain, noting need for new treatments for the condition The PBAC has recommended PBS listing of Ryeqo for treatment of moderate …
Ward named as new PBAC chair
Outgoing MSAC chair, Professor Robyn Ward, will take on the leadership of the PBAC this May Professor Ward, the executive dean of the Faculty of Medicine and Health at the …
PBAC backs early supply rule change
Government extends Safety Net early supply rule for 60-day scripts to reduce medicines wastage Changes to the Pharmaceutical Benefits Scheme (PBS) Safety Net early supply rule come into effect today …
Ozempic diabetes competitor gets PBS knockback
Eli Lilly’s Mounjaro would need “substantial price reduction”, says PBAC Mounjaro, the type-2 diabetes medication that the New York Times recently predicted “’could overshadow Ozempic” has been refused funding via …
Guild seeks ‘sensible way forward’ on double dispensing
Community pharmacists are being urged to “keep the pressure on the government” to limit the adverse impacts of 60-day dispensing Government officials need to restart negotiations with community pharmacy leaders …
Double dispensing a breach of trust: Twomey
Trust between the government and community pharmacy is broken, Professor Trent Twomey, Pharmacy Guild of Australia national president believes Labor’s decision to push ahead with its plans for 60-day dispensing …
PBAC ‘has now seen sense’ on fluticasone
The controversial decision to restrict prescribing fluticasone propionate for young children has been reversed in a move welcomed by the Guild But families and pharmacists have been left without clear …
Butler considering 60-day dispensing
Increasing dispensing limits from 30 to 60 days’ supply of medication through the Pharmaceutical Benefits Scheme (PBS) is back on the agenda Ahead of the federal Budget in May, Mark …